Viewpoints

Faced with divisive political and social issues, Congress must find a way to reach consensus.

The review of batch records creates a story of the materials, manufacturing, and packaging involved in the production of bio/pharmaceuticals, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.

Amid debate about “fake news,” peer-review papers offer vital, objective insight.

New reports address biopharma’s leading concerns: funding for drug development and pricing of finished drugs.

New reports indicate that drug prices are slowing compared to other healthcare costs.

Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.

Pharmaceutical companies need to radically change to survive and thrive amid shifting healthcare and technology changes.

New study will reveal bio/pharma practices and performance on quality issues.

Siegfried Schmitt, PhD, Principal Consultant at PAREXEL, discusses how to gain benefits from interactions with industry associations.

Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the value of internal audits and how the information gained can be applied.

Philadelphia plays host to the exhibits, conferences, and networking activities of CPhI North America on May 16-18, 2017.

Drug type, potential sales, and ownership factor in the race to get drugs to market.

Siegfried Schmitt, PhD, Principal Consultant at PAREXEL, discusses how to mitigate risk in a global regulatory environment.

Pharmaceutical Technology spoke with Tommy Fanning, head of biopharmaceuticals for IDA Ireland, to get a perspective on how Brexit may affect the pharmaceutical industry.

Reducing regulatory roadblocks requires more than the stroke of a pen.

Report: Global medicine spending will reach nearly $1.5 trillion by 2021.

Rookie API developers beat pharma at its own game.

CPhI Pharma Award winners were recognized for sweating the details for the bigger picture.

Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.

BioPharm International editors seek bioprocessing experts to contribute technical articles in 2017.

Steep price increases for a popular drug have created patient and Congressional backlash.

Congressional partisanship creates noise, but no funding for Zika virus research.

CPhI Pharma Awards seek nominations for excellence in biopharma development and manufacturing.

Advances in single-use systems, consumables, and continuous manufacturing show steady progress.

Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses how to report quality metrics to FDA.

Policies for patient access to life-saving therapies must keep pace with biomedical innovation.

Proven science-based strategies can help to accelerate vaccine development.

Thought leaders tackle drug shortages and biomanufacturing challenges.

Report: Biologics contribute to rebirth of biopharma innovation.

Infrastructure and payer decisions will determine drug choices in emerging and developed regions.